! " #$
%& ' ( ()* $+%
! ", -. /%
%0# 1 ", "2#3 01 ' ! " #$ 4 . 5 ,3 6 7 8
9# :
; : )-<
=>?
@A ) -73
=CA?
(
:E 3 1 :F%G H3%0* H 1 *3 :H3%0** / I 2,J "7 0 " 5
K : . M : OCPC
=P=QQ [email protected] :
" R H 1 S3 G "T3 * % UV*
2G 3 ",J
@ / (W,3
6 7 3 , 2 /
$ 0 3 X %YG3 " . :=
4 7 Z 9)
%-< ( < :; C/
:
%2G
/ % Z% .
P*
:
%2G
" X 3 7 :Q
%2G , 1 < ,3 %
"
O
# 3 # G=
1 J T / T 7
"
T [
"
: 5 / I 2,J "7 0 "
()* $G%
J%T\ 87\ ' ( /
H3%0* :
] ,3 ;
/ 3%2G / I 2,J T [T
"
: / I 2,J "7 0 " 5 H3%0* :
# 3 # GC
/J T 1 %[
/ I 2,J "7 0 " 5 H3%0* :
,3 P
I 2,J T [T
"
:
"7 0 " 5
/ I 2,J
H3%0* :
273Q
7 #
"
T 7
"
T [T
"
E ' WT ^ $G% : /
! ! 5 ,3
:
%0# 1
273O
1
# 9
"
: / I 2,J "7 0 " 5 H3%0* :
[_
: HJ H 1 E 3$ 3 S3 G "T3 * 1 R
"* G / 73 # `a
.
" b Z c 3 1 * 1 / 9,3 * c 3 3 H3 *
c d* % H 1 E 3$ 3 0
%G -273 G%* , / .
e 3
: 2G HJ H 1 H %1 f 1 g 1 7 :/ (W,3IX
", ,3 % T 5 2 7 %* % 1 $0] ", 1 /3 CMV)
( G
2G HJ " I H 1
# $ 0]* S3 G "T3 * 1 : #3 6%2 G )* 3 IX .
* 3 h V 7 )<
i : G%* , 3%j9 1 7 c 3
I 7 2G G H 1 R IX
S3 G ) 1 Yk 6%2 G H3 . (
97l I pcDNA3
) 1
"- 6%2 G H3 . (
c [- ,3%* /3%1
6 7 H3 9a* / _ %2
"
CHO) (
\ 7 2 %& 3%R -273 m(2 E .
6 7 G n )
,3%* / j1 j# [-
2G H 1 / 7 [#\ o
", ,3IX 3 h
; C p9
X% I H \ / \
%& 3%R (W,3 /3 .
2 :
"- 6%2 G 1 ( \ 7 1 2, 2G H 1 %5, 1
6 W IX
* 6 7 %& n7
# [- ,3%* / 1
97l G%* , / 1
. 6 7 %& H 1 H3$ " 3 213 (
# [- ,3%* / G%* , 7 1
H 1 E 3$ 3 %5, , :
6 7 n7 * / X G 73 "
2 S3 G "T3 * .
] 2, /% &
:
* %1 l.
V 1 %1 S3 G 3$ 3 E(, 2G H
WT ^ /3%1 "Y7 3$13 ", 1 / 97l ! 7 1 q% c 3 :IX
2G H 1 I * 92 7
", ,3IX
# 8 3% 6 W .
/ G H &J3 :
HJ :S3 G "T3 * 2G : G%* , c d* % :"* G /
IX
T ( :
;Q /
=;
/ AO T ( e% s :
P / C / A?
!"
#" $ %# & #' ( )
* + in vivo
ex vivo )
- .(
0 1%
22%
0 !3 4 3 ( 5 # 6'
7# 2%
7 1 $ %# & #' 8
!
9 : ( ( 5 #
. B 1 3
( ; 6 #%
7< = >? % @ # 6
% 3 A % B
C+ D
* + 8
E ( #% 6 F 1G H X
# !
IJJJJ / -
L #
) M .(
N 3 O ! 1
B 7 # <' ( 8 P #Q $ %#
R 6
.
$ %# C 8 S 0 !3
& #' # 2 & #' 2 ( $ %#
)
#+ 2 !L? <' (
2 !3 0 T % U2 )
I .(
V
7 1 U2 #+ 2 1%
%
2% #' P = C= WX % # Y D 8 )
Z [
\ .(
0L
# Y D %
% WX
8 7< = $
L 2 8 1 ( #X 2 6
%
#+ 2 U2
# Y D
WX %
] 22%
)
^ ( .
8 = 28 #+ 2
! _ U2 1% 0 % %
# #' C 8 V
0 !3
2 S
6 2 =
!
S
`
#3 #a
T 2 1' T
<
2 6 )
-J [ b .(
0 !3 U2 = 1Ac %
% 3 B
!" :
2 #% # #' U2 #+ 2 (
# 2 !
_ #% ) 1X
) --
-M .(
# <
%W d 8 = 28 #+ 2
# C c # Y D e '
I ' L
#f%
%
#+ 2
#c
# X _ U2 %
Q6 ( @
# L
) -J [ b .(
* % # _ U2 9 S 1 #'
]
# a
7 S = Xg
#c mRNA
) -I .(
<%
m7G 5 ) -\
(
7 S S =
-
mRNA
S A
: #V
h #8 % AUG )
(
# ) -e -Z -^
(
h #8 % "
) -b (
#A S 7 V
) -B
MJ ( ' i S > a = !
# h #8 %
) -^
M- MM ( - Xg
7 S (
* % mRNA
#'
# h #8 g # % 2 6 S 1
9 ] _ U2 T #c # a 22%
. S
S 1 ( j ( %
= 28
( U2 d 8
Xg
7 S =
#f% mRNA
* % h #8 _ U2 % S 1 #'
#
% k )
-Z MI .(
S
' L e
#f%
% 2 & #' WX
* +
GCC(A/G)CC l h #8 % ( CAc
# AUG ) (
#c
C 2 # X
C E ( A m h #8 % 28
2%
) -Z MI .(
n !X
@ k
%
0L o
S
?
%
# % # h #8
`
h p % #a
H3 [9 $ 0 3 X H 1 S3 G "T3 *
2G
@ t (W,3 /
=>>
j ( % S
! k )
M\
( .
# T % # i S C E!
Q % 9+ # i >?
2
# h #8 % )
M\
Me .(
* @S o
k l1 Q
j ( % S qD %
& #' 0 !3 $ 8
) MZ .(
%W $S o 0 !3 1 c j ( % S
& #' $ %#
. 0 g'
% 3 # i :
B
#c @
# h #8 % ( CAc j ( % S ATG ) (
% 3 ( 2
B
# 2 %
-
6 1X
) -- ( c
% 3 B
7 1 6
# 6 Q
CHO 2 r 3#X #c @S o
.
e 3
G
/%2+ 1 e 7 97l :H3 3 , 2 "T 7 i :
%9 3%
:
# N n 1% k #8
) g # [ s # T (
CD # # 6
(
8 )
. S 1 d
# S 1 5 ( 8 #= CHO
% 3 L 6' S 1 ! 2
B
3#X #c ) .
$ %# d(
pET26-
hFIX-I )
-- (
!3 L "S 2
#3 j ( % S T
PCR 2
8 )
.
<' O 9 pcDNA3
)
# 2 [
s # T (
d( D #V # ' % 2
% 3 B 7 1
) 6'
3#X #c .
(
8 =
T 6 2 5
t= 8 2
2 6 Q
.
# #' 8 )
O 9
# ( u#8 ST %#8 m
MWG
8 = .
8 $,\ : + n ) 9 # 3 :
+ "
:
kN m 9 LB
# N kN m 9 2
v8 ) .
w T 1
C ' #' ! 6 %
( %i X IPTG )
Xgal ( )
$ #
U1Y -JJ IJ MJ MJ
5 E#X #
1 k% m 9 # S (
( * +
8 ) Q kN m 9
. _ ! T NotI
DraI T4 DNA Ligase 6 2
G-418 ) (
N
7 x9 t 1Q
<' PCR C
3 ks)6 # Z
N#8 ( n
) ST (
#=
#X . _ ! T BamHI
<'
y2 1%
pTZ57RT 8 #= ( 2 #3 (
.
<' N 3 c 3
B N#8 ( 6
"
) 6 #3 (
8 #=
. 6 @ AV <'
N 3 @ 6 _ :
B
# = 7 ( ( z * +
T . m 9 DMEM k%
{
Hams-F12 sA X %#8 (
) s # T (
8 L
CHO 7 1
8 )
.
7 /
DNA
/ :
DNA (
n | #
8 E ? y2 1N )
M^
.(
$ %# d(
pET26-hFIX-I
# f L "S 2
$ %# >@oc K-E1-I1-E2-4
) C 8 @oc
!X -
\ 7 S
% 3 cDNA B
4Luria-Bertani
Dulbecco’s modified Eagle’s medium
:
5'GGATCCGCCACCATGCA GCGCGTGAACATGAT 3´
hFIX-K-E1-F
5' CCT TGC AAC TGC CGCC ATTTA AAC 3'
hFIXE4-R
# 2 % -
C+ 3 D 1X
!X -
M
#c T (
8 )
.
S}
j ( % S 4 9
% 3 cDNA }
B
#c }
S #'
}
#
hFIX-K-E1-F 8 # W'
.
E ? U2
6 C
~ L (
e #' }
#
hFIX-K-E1-F hFIXE4-R
" $ #
BamHI ! T 8 D #V DraI
.
"T3 * c W*
:
6 j ( % S qD 9+
8 (
d(
pcDNA3-K-hFIX-I $ N#
)
(
S @
"
ABI 373 )
ST [
( MWG
# #' ( ) + x =
] #X .
c [- ,3%* 6 7 G :
CHO 7 1 I^
>
k3 #X
#)6 e CO2 % k% m 9 Hams-F12
A6 DMEM -
/ -
% -J + 2 E# (
U/ml X -JJ 2' G 1
100 µg/ml
'#
8 8 8 2Y 6
.
k 3 w S n k )6 # 1'
08
= 3#X * + .
U2 #
7 1
D CHO M\
ks)6 # 02N ( CAc
_% # JJJ / – -IJ JJJ / --J
= # ( 7 1
8 kN
. ks)6 # 02N # n
k 3 w S I
?l3 [
?l
Z B^
' k% m 9
) c 3 T E#
5 (
* € 1Q e
c
* #D 4
8 #c
. 4 3 € 1Q
M
?g$ %# <' € 1Q ( ;' 3 p
Cc D * IJ
8 #c 4 V c
.
L € 1Q
• 6 ;w
1 ml 7
M #X 3 p ' kN m 9
. ks)6 # 02N
* #
Cc D Z 3
.
;w m 9
k%
‚ ' T
k% m 9 7 1 C N
#X 3 p .
( E ks)k # ( ;' E
‚ # # kN m 9
( m 9 T
7 1 8 3 p .
3 ,3 2+ / (W,3 T W /% &
@
", ,3 :
N 3 ƒ S S @3 B
( ) 8
N 3 c 3 6 <' PTT B
7 @3
„
8
N#8 1 8 _ #3 C @S O o S
22%
#X @ .
% 3 S @3 ! Q #
B
( 8 6
8 )
%
@ S @3 ( ) e
c l1 Q (
<'
# 8
@ AV 6 ) -ZJ / - bJ / -
\J / - MJ / - -J / - ( "S E WY N 1 #
_ # @ (
8 .
@ 6 E ? #
-JJ
?l(
?l
# -JJ c 3 <' (
N 3
?l
B -JJ PTT ( 7 @3
• c € 1Q 8
I
* #D c
I^
#X
#c
8 .
?l
;w -JJ
#1N _ 61N Me mM
CAc (
8 E#X I^
#X ( 3 p T
( @
8 # X
@ S @3 #
#
| #X @
.
2
I 7 ! 7 G%* , /
:
= }
$ %# d(
pcDNA3-K-hFIX-I
: }
# i }
% 3 } B S 1 d
\ CHO
* + % 3# W' * + 1D#
C 8 5 8
- 8 0 .
3Activated Partial Thromboplastine
H3 [9 $ 0 3 X H 1 S3 G "T3 *
2G
@ t (W,3 /
=>;
m[#
= : , / 7 ! 7 I * 9# mX3%
", 1 n73 X G%*
@oc ƒ 7 1D#
7 V IBI
% ( )
!X j ( % S D -
# 2 - 1X
!X M
\
% 3 K-E1-I1-E2-4 )
(
%
" !L?
! T n#
BamHI/DraI
n = L
( ) PCR
d(
pET26-hFIX-I $ %#
) -- (
"S 2
#X # f .
<' >@oc @ >1D#
pTZ57R/T 6
$ %# d( 8 (
pTZ57R/T- K-E1-I1-E2-4 T
. _q # '
( pTZ57R/T- K-E1-I1-E2-4 $ %#
pET26-hFIX )
-- ( _ ! T >1
BamHI/DraI
>@oc K-E1-I1-E2-4 $ %#
>@oc !"
E1-E2-4
$ %# d(
pET26-hFIX
$ %# d( #X
pET26-K-hFIX-I T
. 9+
=
d(
NW $ N#
( )
S sS ! S T ]
#X . ( ZBMI o= Cs8 ( )
$ %# d(
pET26-K-hFIX-I 1
_q
_ ! T X BamHI
XhoI N DraI
n# " ƒ m 3
$ %# d(
4 3
2 6 ] 8 ) C 8 M [ lS .(
>?
_q
pET26-K-hFIX-I d(
_ ! T
DraI /BamHI DraI /BamHI
@oc $ #
7 V
\^-
\eM eIMM -ZJ-
( )
U
8 k 7 _q ( ;' %
) C 8
M [ lS .(
2 :
[#
m
; : G%* , / 7 "T [T $ T ,\
. uT3 : G%* , i 7 pET26-k-hFIX-I
u
= : Hind III%G .
u
; : 97l
pET26
u :
C : G%* , i 7 pET26-K- hFIX-I
: u P : Q O : m[#
/
# "^!
pET26-K-hFIX-I *%* 1
1
BamHI NotI :
u :DraI
? : 43 * 8v K-hFIX-I-pET26 8 $,\ 1
BamH I u :DraI
A : 43 * 8v pET26-
hFIX-I BamHI 1
.NotI : G%* , i 7 pcDNA3-K-hFIX-I
. u
= :
%G 3 Y f Hind III u
; : 8v i 7
G%* , pcDNA3-K-hFIX-I BamHI 1
u C : 8v i 7 G%* , pcDNA3-K-hFIX-I NotI 1
u :
P : 43 * 8v
pcDNA3-K-hFIX-I BamHI 1
.NotI
1D#
#=T
m D $ %# d( _q
pET26-K-hFIX-I
<' pcDNA3
_ ! T
BamHI/NotI 6
cDNA (
$ %#
% 3 B
<' j( % S !L? %
pcDNA3
$ %# d( 8 E ?
pcDNA3- K-hFIX-I
T . 9+
=
$ %# d(
pcDNA3-K-hFIX-I
( )
S sS ! S T
) C 8 M [ F (
] S @
#X .
6 7 c [- ,3%*
CHO
/ 7 1 / G%* , :
:
# j ( % S #a # N 3
B
@
lS
M-MMZ e-\b MJM^
eZ\
- M I \ e Z ^ b M-MMZ
e-\b MJM^
eZ\
F
- M I \
H3 [9 $ 0 3 X H 1 S3 G "T3 *
2G
@ t (W,3 /
=>P
CHO 7 1 7 1
kN ( ;' 8 M\
_% # eJ
^J
:#… †o +
#
ks)6 # (
pcDNA3-hFIX- $ %#
) I -- pcDNA3-K-hFIX-I (
n ( )
k 3 w S )
2 3#X #c .
k )6 #
' <' pcDNA3 )
( ! )2 7# 2% 2
3# W' * + .
S # a] # :
T # j ( % kN m 9
7 1 8 )6 #
( E ks)6 # 02N ( ;' E
‚
8 T
. 2
( $ %#
8 = 6 2
2 6
7 1 Q m 9 9 µg/ml U1Y
\JJ (
8 #c 6 2
# f (
7 1
#X #?2 <' .
‡# R
7 1 )6 #
k
( ;' ( 2r
6 2 .
S D : #… % 7 1
7 1 8 )6 #
c
7 1 %
\ e )
@ 21% 2r ( 0 7 1 (
C k $ %#
.
H 1 "7 %1 2G
@
", ,3 :
m 9
‚ kN
8 T
7 1 (
8 )6 # (
E ( ;' E
ks)6 # 02N L
S D
% 3 B
1D# ƒ @ 6 ( )
#
3#X #c 2
.
@ (
* )
ks)6 # 8 s)6 #
pcDNA3-hFIX-I Af 7# 2% 2
pCDNA3 7 1
k s)6 # 2
% 8 6 )2 7# 2%
#" k 2@ 0 N
@ (
8 )6 #
<'
% 3 22%
7# 2% 6 IX
)2 )
C 8 I ( .
m[#
C : 6 7 3 \ 7 1 G n ) / (W,3 T W "7 %1 G%* , i 7 1 # [- ,3%* /
pcDNA3-K-hFIX-I
1 (
6%2 G . 3 9, uT3 : PA c [- ,3%* 3 W1 . 7 .
3 9, :
?;
c [- ,3%* 3 W1 . 7 .
6 7 3 G n ) /
1 , [- ,3%*
6 7 3 G n ) N 1 # [- ,3%* /
pcDNA3 NC 1
# 3 H , ,3
.
†8# @ S @3
% 3 B m $ N#
7 1 kN m 9 8 s)6 #
k
. 7 1 m 9 @ ( 0 % )6 #
6 E ( j ( % S d( 8
7 1 m 9 Af 7# 2% 8 )6 #
]
# a
% 3 0 !3 j ( % S qD A
B
8T .
@ (
kN m 9 @ S @3
ks)6 # 02N # ( T (
$ %#
6 _ 7# 2N C 8
I z
8 .
% 3 ! 1 5 IX
@ AV = # S
7 @ 6
eJJJ 7 @ 2@ E#X
-JJ +
5 S S @3 )
eJ ( E#X -
+ S @3
5 S ( 3#X #U 8
) Mb .(
6
C 8 T E j ( % S I
F
k
% 3 †o %W S %
( IX MI +
\Z + ) ( --eJ E#X
MIJJ E#X
( V
^M 0 !3
.
w)1
1+ : j ( % S # a] # O 9
% 3 B
6 @
. 0 !3
& #'
( ( ) 2 ( $ %#
2 !3 0 U2 #+ 2 !L?
) I .(
C
_ U2 C =
• D
% # Y WX
3#X #c )
Z [
\ .(
% 8 tQk ( #
Xg
7 S =
* % mRNA -
#' S 1
# †o 6 ( ;' _ U2
L # )
-\
-Z -b -B .(
S =
mRNA 7 S S A
: #V
h #8 %
AUG ) ( Xg (
= - 7 S
L # # _ U2 % mRNA
) -^
[ -e .(
Xg ( j ( % S
=
7 S S
% * ? % mRNA
~ h #8 e
* % #f% T S 1 #'
% k # h #8 _ U2 3#X #c
) -Z MI .(
9+ # i S C E!
# h #8 % 2 Q %
) M\
.(
lc ˆ h #8 % ( CAc j ( % S
% D # ( *
\J s
% * ? E ( A
h #8 0 !3 h #8 % z 28 9+ WS 8
i # % 3
) Me .(
S
l * x
GCC(A/G)CC h #8 % ( CAc
7 S #f%
* % mRNA
#c S
2r # # X S
! #"
8 ) -Z MI MB .(
0L o
% 2 !"
0 (T
‰)D 8 z )1 Q
%W S k & #'
) -b IM [
IJ .(
0 (T j ( % S # G % 2%
#c # a] 9 & #' .
k * 9
l * + j ( % S %
GCC(A/G)CC )
' j ( % S (
( 9
mRNA 7 S 7 1
% C % V
8 ‰)D )
-I .(
" S I
[ A6
h #8 %
(GCC(A/G)CCAUG ) 1% 0
8 .
8 ‰)D • 8 " WS
V
% B^
7 S +
mRNA
* %
ST ( S
T g 2 '
A ) ( 6 "
2 ) -e .(
$S o
0 (T ( 6 %W
j ( % S #"
& #' 0 !3 1 c $ %#
. ( WS
S
# i L ! 2
#% ) & #' )
II .(
# k
h #8 % ? %
% 3 B
@ AV S D
' j ( % S k 6 % 8 … )D S
#c )
I\
.(
j ( % ' S ( WS
# i L
% 3 cDNA B
#% ) .
2 S 2r ( ) % #%Š E(i
# i L 1
% 3 cDNA
B
H3 [9 $ 0 3 X H 1 S3 G "T3 *
2G
@ t (W,3 /
=>O
k n !X 6
.
S # a]
-
face # U ( 5r % D # ( WX % C %
8 n !X 1% k #8 # % j )
MZ .(
D % 8 k * 9 T
# #' ( ) * + % #'
qD %
0 !3 j ( % S .
j ( % S # 2 L T % !
& #' l1 Q h # i $ %#
_ 6 8 %
. 0 g'
% 3 B
# #' 7# 2% 9 @ V CMV
% S qD !?
S 1 d j ( CHO
_ #% # .
T 7 S #f% %
7 1 mRNA
" % I
[ A6
l ( T ST ( h #8 %
GCCACC
" ST ( % I
[
_ #% ) .
# j ( % S #a # U2
N 3 B
@ CHO 7 1
kN m 9
‚ ( 8 T E
02N ( ;' E
ks)6 # L
S D
% 3 B
( )
1D# ƒ @ 6
3#X #c # .
(
@3 S
m 9 ( T @
‚ k%
1 ( 8 T 7
8 )6 #
(
S j ( % S c 3 $ %#
( $ # II /
^I II /
^Z 7 @ a Ie
MI +
ZB ZZ
7 @ a
Ie
\Z
<' S @3 +
# G 6 7 #
. S @3 @ ( * )
% 3 @ B
) m 9 (
‚ 8 T
7 1 ( ( 8 )6 #
k $ %#
% 3 * ) d 2 B
qD E qD
j ( % S .
S Af % * )
% 3 0 !3 j ( % B
k .
R
* 9 ( C+ D
% S 0 !3 j (
% 3 †8# S B
k% m 9 7 @3 ]
2%
. k R #" :#V ( S % 2
j ( %
# # i L $ 2 1
8 6
.
%[ * % (*
# #+ # % cT ( S X 26
(
= L
8 WX 6 @ AV <'
c +
2 .
References: __________________________________________________________
1.Garlick JA, Fenjves ES. Keratinocyte gene transfer and gene therapy. Crit Rev Oral Biol Med 1996; 7:204-21.
2. White SJ, Page SM, Margaritis P, et al.
Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo. Hum Gene Therapy 1998; 91187-95.
3. Makrides SC. Components of vectors for gene transfer and expression in mammalian cells. Protein Expr Purif 1999; 17:183-202.
4. Fong YW, Zhou Q. Stimulatory effect of splicing factors on transcriptional elongation.
Nature 2001; 414: 929-33.
5. Ismail SI, Kingsman SM, Kingsman, A J, et al. Split-Intron Retroviral Vectors: Enhanced
Expression with Improved Safety. J Virol 2000; 74:2365-71.
6. Rohrer J, Conley ME. Transcriptional Regulatory Elements within the first intron of bruton’s tyrosine kinase. Blood 1998; 91:
214-21.
7. Hirosawa S, Fahner J B, Salier JP, et al.
Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.
Develop Biol 1990; 87: 4421–5.
8. Larizza A, Makalowski W, Pesole G, et al.
Evolutionary dynamics of mammalian mRNA untranslated regions by comparative analysis of orthologous human, artiodactyl and rodent gene pairs. Comput Chem 2002; 26:479-90.
9. Pesole G, Mignone F, Gissi C, et al.
Structural and functional features of eukaryotic mRNA untranslated regions. Gene 2001; 276:73-81.
10. Spicher A, Guicherit OM, Duret L, etal.
Highly conserved RNA sequences that are sensors of environmental stress. Mol Cell Biol 1998; 18:7371-73.
-- .
h ! Lk D
h ' # ( P | 2 6D
.
# a
# 2 -
# 6 1X
N 3 c B
@ 7 @3
7 1 ( 6
6' .
= 1?
e 8
\
‹ MI [ MJB
-M . P | 2 6D
# ( h ' 7<
. D #V
E ' 2 #N + x = N =
N 3 #
7 2 6 IX .
= 1?
I 8 -
‹ M^
[ -^
.
13. Kozak M. An Analysis of Vertebrate mRNA Sequences: Intimations of Translational Control. J Cell Biol 1991; 115:
887-903.
14. Shatkin AJ. Capping of eucaryotic mRNAs.
Cell 1976; 9 :645-53.
15. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes . Cell 1986; 44 :283-92.
16. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196:
947-50.
17. Kozak M. Context effects and (inefficient) initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol Cell Biol 1989; 9 :5073-80.
18 . Kozak M. Translation of insulin-related polypeptides from messenger RNAs with tandemly reiterated copies of the ribosome binding site. Cell 1983; 34 :971-8.
19. Kozak M. A short leader sequence impairs the fidelity of initiation by eukaryotic ribosomes . Gene Expression. 1991; 1 :111-5.
20. Kozak M. Effects of long 5' leader sequences on initiation by eukaryotic ribosomes in vitro. Gene Expression 1991; 1:
117-25.
21. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci USA 1986; 83:
2850-4.
22. Kozak M. Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes. Proc Natl Acad Sci
USA 1990; 87 :8301-5.
23. Kozak M. Regulation of protein synthesis in virusinfected animal cells. Adv Virus Res 1986; 31:229-92.
24. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position 4 but is not generally affected by the nucleotides in positions 5 and 6. EMBO J 1997; 16:2482-92.
25. Harkins S, Cornell CT, Whitton JL.
Analysis of Translational Initiation in Coxsackievirus B3 Suggests an Alternative Explanation for the High Frequency of R+4 in the Eukaryotic Consensus Motif. J Virol 2005; 79: 987-96.
26. Michelon A , Michelon M, Simionatto S, et al. Effect of the kozak sequence on seroconversion of mice immunized with a DNA vaccine agenst swine colibacilosis. Braz J Microbiol 2003; 34: 85-7.
27. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. USA:
Cold spring harbor laboratory press, 2001.
28-Miao CH, Ohashi K, Patijn GA, et al.
Inclusion of the hepatic locus control region , an intron and untrranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Molecular Therapy 2000; 1:522-32.
29. Caveneer, Comparison of the consensus sequence flanking translational start sites in Drosophila and vertebrates. Nucleic Acids Res 1987, 15: 1353-61.
30.Johansen H, Schumperli D, Rosenberg M.
Affecting gene expression by altering the length and sequence of the 5' leader. Proc Natl Acad Sci USA 1984; 81:7698-702.
31. Kozak M. Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin invivo. Nature 1984; 308:241-6.
32. Kozak M. Selection of initiation sites by eukaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin. Nucleic Acids Res 1984;
12:3873-93.
33. Christopher R, Erwin M A, Helmrath C E, et al. Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection. Am J Physiol Gastrointest Liver Physiol 1999; 277: 440-533 34. Pang CP, Crossley M, Kent G, et al.
Comparative sequence analysis of mammalian factor IX promoters. Nucleic Acids Research 1990; 18:6722-31.